DiekmannF., BuddeK., OppenheimerF., FritscheL., NeumayerH.H., CampistolJ.M.Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction. Am J Transplant2004; 4: 1869–75.
2.
LarsonT.S., DeanP.G., StegallM.D.Complete avoidance of calcineurin inhibitors in renal transplantation: A randomized trial comparing sirolimus and tacrolimus. Am J Transplant2006; 6: 514–22.
3.
RuizJ.C., CampistolJ.M., Sanchez-FructuosoA.Increase of proteinuria after conversion from calcineurin inhibitor to sirolimus-based treatment in kidney transplant patients with chronic allograft dysfunction. Nephrol Dial Transplant2006; 21: 3252–7.
4.
IzzedineH., BrocheriouI., FrancesC.Post-transplantation proteinuria and sirolimus. N Engl J Med2005; 353(19): 2088–9.
5.
Gutiérrez-DalmauA., CampistolJ.M.Kaposi's Sarcoma after renal transplantation. N Engl J Med2005; 353(8): 846–7.
6.
KanitakisJ.Kaposi's sarcoma after renal transplantation. N Engl J Med2005; 353(8): 846–7.
7.
McCaffreyP.Sirolimus does double duty after organ transplantation. Lancet Oncol2005; 6(5): 261.
8.
ZmonarskiS.C., Boraty skaM., Rabczy skiJ., KazimierczakK., KlingerM.Regression of Kaposi's sarcoma in renal graft recipients after conversion to sirolimus treatment. Transplant Proc2005; 37(2): 964–6.
9.
DantalJ., SoulillouJ.P.Immunosuppressive drugs and the risk of cancer after organ transplantation. N Engl J Med2005; 352(13): 1371–3.
10.
StalloneG., SchenaA., InfanteB.Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med2005; 352(13): 1317–23.
11.
SandriniS., SettiG., BossiniN., MaiorcaP.[Cancer after kidney transplantation]. G Ital Nefrol2004; 21(suppl 26): S67–73. Review. Italian.
12.
CampistolJ.M., Gutierrez-DalmauA., TorregrosaJ.V.Con-version to sirolimus: a successful treatment for post-transplantation Kaposi's sarcoma. Transplantation2004; 77(5): 760–2.
13.
BurgosF.J., AlcarazA., CastillónI.Present and future of kidney transplantation]Actas Urol Esp2002; 26(10): 731–58. Review. Spanish.
